Dicerna Pharmaceuticals Inc (OQ:DRNA)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for DRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Nov 9/18 Nov 8/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -107,920 $14.86
Nov 9/18 Nov 7/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -250,000 $14.74
Nov 6/18 Nov 6/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -263,300 $13.84
Nov 6/18 Nov 6/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -11 $14.16
Nov 6/18 Nov 6/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -1,489 $14.16
Nov 6/18 Nov 6/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -761 $13.18
Nov 6/18 Nov 6/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -102,067 $13.18
Nov 6/18 Nov 5/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -71,400 $12.89
Nov 6/18 Nov 5/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -295 $12.98
Nov 6/18 Nov 5/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -39,606 $12.98
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for DRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Nov 9/18 Nov 8/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -107,920 $14.86
Nov 9/18 Nov 7/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -250,000 $14.74
Nov 6/18 Nov 6/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -263,300 $13.84
Nov 6/18 Nov 5/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -71,400 $12.89
Nov 6/18 Nov 2/18 Kolchinsky Peter Indirect Ownership Common Stock D - Disposition to issuer under Rule 16b-3(e) -175,700 $13.49
Nov 6/18 Nov 6/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -11 $14.16
Nov 6/18 Nov 6/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -1,489 $14.16
Nov 6/18 Nov 6/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -761 $13.18
Nov 6/18 Nov 6/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -102,067 $13.18
Nov 6/18 Nov 5/18 Halak Brian K Indirect Ownership Common Stock S - Open market or private sale -295 $12.98
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $DRNA

StockTwits